Companies House true 2023-03-27 2024-03-31 true 14761956 uk-bus:Director1 2023-03-27 2024-03-31 14761956 uk-bus:Director2 2023-03-27 2024-03-31 14761956 2023-03-27 2024-03-31 14761956 2024-03-31 14761956 uk-bus:EntityHasNeverTraded 2023-03-27 2024-03-31 14761956 uk-bus:FRS102 2023-03-27 2024-03-31 14761956 uk-bus:FullAccounts 2023-03-27 2024-03-31 14761956 uk-bus:AuditExempt-NoAccountantsReport 2023-03-27 2024-03-31 14761956 uk-bus:OrdinaryShareClass1 2023-03-27 2024-03-31 14761956 uk-bus:OrdinaryShareClass2 2023-03-27 2024-03-31 14761956 uk-bus:OrdinaryShareClass3 2023-03-27 2024-03-31 14761956 uk-bus:PreferenceShareClass1 2023-03-27 2024-03-31 14761956 uk-bus:PreferenceShareClass2 2023-03-27 2024-03-31 14761956 uk-bus:PreferenceShareClass3 2023-03-27 2024-03-31 14761956 uk-core:ShareCapitalPreferenceShares 2024-03-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 14761956

SISION BIOMEDICINE AND CELL TECHNOLOGY CO., LTD

Dormant Accounts

31 March 2024

SISION BIOMEDICINE AND CELL TECHNOLOGY CO., LTD Registered Number 14761956

Balance Sheet as at 31 March 2024

2024
£
Called up share capital not paid
50000
Net assets
50000
Issued share capital
50000 Ordinary Shares of £ 1 each 50000
Total Shareholder funds
50000

STATEMENTS

  1. For the year ending 31 March 2024 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 7 April 2024

And signed on their behalf by:
YANHUA LOU, Director

NOTES

During the year the company acted as an agent for a person